atorvastatin has been researched along with Depression in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (11.76) | 29.6817 |
| 2010's | 10 (58.82) | 24.3611 |
| 2020's | 5 (29.41) | 2.80 |
| Authors | Studies |
|---|---|
| Cowen, PJ; De Giorgi, R; Harmer, CJ; Martens, M; Rizzo Pesci, N | 1 |
| Abolmaali, M; Hosseinzadeh, A; Khotab, SJ; Mehrzadi, S; Mousavi, SZ; Nikoui, V | 1 |
| Cong-Rong, T; Fan, Y; Hai-Na, Z; Jing, L; Lei-Mei, X; Ruo-Lan, S; Xu-Ben, Y; Yan-Cheng, C; Ye-Xuan, W | 1 |
| Fan, H; Huang, J; Lai, X; Liu, A; Ma, H; Shen, M; Sun, W; Wu, J; Xu, Y; Yan, J; Yang, J | 1 |
| Chen, BL; Chen, SM; Lai, CP; Lee, CH; Lee, JA; Lee, MC; Peng, TR; Shiang, JC; Wang, JY | 1 |
| Cook, RL; Dave, CV; Hartzema, AG; Park, H; Winterstein, AG | 1 |
| Drosdzol-Cop, A; Krysiak, R; Okopień, B; Skrzypulec-Plinta, V | 1 |
| Buss, ZS; Doneda, DL; Ferreira, YS; Fraga-Junior, EB; Lima, E; Lopes, L; Rios-Santos, F; Stupp, IJV; Taniguti, EH; Vandresen-Filho, S; Viola, GG | 1 |
| Binder, LB; Constantino, LC; Cunha, MP; Dal-Cim, T; Kuminek, G; Ludka, FK; Rodrigues, AL; Tasca, CI; Zomkowski, AD | 1 |
| Dehpour, A; Jahanabadi, S; Javadi, S; Khoshnoodi, M; Mehr, SE; Shafaroodi, H; Shahsavarian, A; Shamsaee, J | 1 |
| Berk, M; Li, X; Redlich, C; Sundquist, J; Sundquist, K; Williams, LJ | 1 |
| Abbasi, SH; Akhondzadeh, S; Beglar, AA; Forghani, S; Mohammadinejad, P; Salehiomran, A; Shahmansouri, N; Zeinoddini, A | 1 |
| Binder, LB; Constantino, LC; Dal-Cim, T; Ludka, FK; Rodrigues, AL; Tasca, CI; Zomkowski, A | 1 |
| Davies, GR | 1 |
| Cunha, MP; Dal-Cim, T; Ludka, FK; Rodrigues, AL; Tasca, CI; Zeni, AL; Zomkowski, AD | 1 |
| Jick, H; Jick, SS; Yang, CC | 1 |
| Browne, P; Connor, DJ; Johnson-Traver, S; Launer, LJ; Lochhead, J; Lopez, J; Petanceska, S; Sabbagh, MN; Sparks, DL; Wassar, D; Ziolkowski, C | 1 |
1 review(s) available for atorvastatin and Depression
| Article | Year |
|---|---|
Effects of various statins on depressive symptoms: A network meta-analysis.
Topics: Atorvastatin; Depression; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Network Meta-Analysis | 2021 |
3 trial(s) available for atorvastatin and Depression
| Article | Year |
|---|---|
The effects of atorvastatin on emotional processing, reward learning, verbal memory and inflammation in healthy volunteers: An experimental medicine study.
Topics: Adolescent; Adult; Atorvastatin; Biomedical Research; C-Reactive Protein; Depression; Double-Blind Method; Emotions; Facial Recognition; Fear; Female; Healthy Volunteers; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Male; Middle Aged; Reward; Social Perception; Verbal Learning; Young Adult | 2021 |
Simvastatin versus atorvastatin for improving mild to moderate depression in post-coronary artery bypass graft patients: A double-blind, placebo-controlled, randomized trial.
Topics: Adult; Aged; Antidepressive Agents; Atorvastatin; Coronary Artery Bypass; Depression; Double-Blind Method; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Percutaneous Coronary Intervention; Severity of Illness Index; Simvastatin; Treatment Outcome | 2015 |
Atorvastatin therapy lowers circulating cholesterol but not free radical activity in advance of identifiable clinical benefit in the treatment of mild-to-moderate AD.
Topics: Activities of Daily Living; Aged; Alzheimer Disease; Anticholesteremic Agents; Atorvastatin; Cholesterol; Cognition; Depression; Disease Progression; Double-Blind Method; Female; Free Radicals; Heptanoic Acids; Humans; Male; Mental Status Schedule; Pilot Projects; Pyrroles; Severity of Illness Index; Time Factors; Treatment Outcome | 2005 |
13 other study(ies) available for atorvastatin and Depression
| Article | Year |
|---|---|
Antidepressant-like Properties of Melatonin and Atorvastatin Combination following the Restraint Stress in Mice: A Study of Oxidative Stress Factors.
Topics: Animals; Antidepressive Agents; Antioxidants; Atorvastatin; Depression; Melatonin; Mice; Oxidative Stress; Swimming | 2023 |
Atorvastatin ameliorates depressive behaviors and neuroinflammatory in streptozotocin-induced diabetic mice.
Topics: Animals; Anti-Inflammatory Agents; Atorvastatin; Depression; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Hindlimb Suspension; Hippocampus; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Inflammation Mediators; Male; Mice; Prefrontal Cortex; Streptozocin; Tumor Necrosis Factor-alpha | 2020 |
Atorvastatin improves motor function, anxiety and depression by NOX2-mediated autophagy and oxidative stress in MPTP-lesioned mice.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Anxiety; Atorvastatin; Autophagy; Behavior, Animal; Depression; Gene Knockdown Techniques; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Mice; Movement; NADPH Oxidase 2; Neurotoxins; Oxidative Stress; Parkinsonian Disorders | 2020 |
Comparative risk of lipophilic and hydrophilic statins on incident depression: A retrospective cohort study.
Topics: Adult; Aged; Atorvastatin; Depression; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Incidence; Lovastatin; Male; Middle Aged; Pravastatin; Propensity Score; Retrospective Studies; Risk Factors; Rosuvastatin Calcium; Simvastatin; Suicide, Attempted; United States | 2018 |
The effect of atorvastatin on sexual function and depressive symptoms in young women with elevated cholesterol levels - a pilot study.
Topics: Adult; Anticholesteremic Agents; Atorvastatin; Depression; Female; Humans; Hypercholesterolemia; Pilot Projects; Sexual Dysfunction, Physiological; Surveys and Questionnaires | 2018 |
Atorvastatin prevents lipopolysaccharide-induced depressive-like behaviour in mice.
Topics: Animals; Antidepressive Agents; Atorvastatin; Behavior, Animal; Brain-Derived Neurotrophic Factor; Depression; Depressive Disorder; Disease Models, Animal; Fluoxetine; Hippocampus; Lipopolysaccharides; Male; Mice; Neuroprotective Agents; Oxidative Stress; Prefrontal Cortex; Tumor Necrosis Factor-alpha | 2019 |
Atorvastatin evokes a serotonergic system-dependent antidepressant-like effect in mice.
Topics: Animals; Antidepressive Agents; Atorvastatin; Brain; Depression; Heptanoic Acids; Male; Mice; Pyrroles; Receptors, Serotonin; Serotonin; Serotonin Antagonists; Treatment Outcome | 2014 |
Antidepressant-like effect of atorvastatin in the forced swimming test in mice: the role of PPAR-gamma receptor and nitric oxide pathway.
Topics: Anilides; Animals; Antidepressive Agents; Atorvastatin; Depression; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Imipramine; Male; Mice; Motor Activity; NG-Nitroarginine Methyl Ester; Nitric Oxide; Pioglitazone; PPAR gamma; Pyrroles; Signal Transduction; Swimming; Thiazolidinediones | 2014 |
Statin use and risk of depression: a Swedish national cohort study.
Topics: Adult; Aged; Aged, 80 and over; Atorvastatin; Cohort Studies; Depression; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Population Surveillance; Pyrroles; Risk Factors; Simvastatin; Sweden | 2014 |
Involvement of PI3K/Akt/GSK-3β and mTOR in the antidepressant-like effect of atorvastatin in mice.
Topics: Analysis of Variance; Animals; Antidepressive Agents; Atorvastatin; Depression; Disease Models, Animal; Enzyme Inhibitors; Exploratory Behavior; Glycogen Synthase Kinase 3 beta; Hindlimb Suspension; Immunosuppressive Agents; Male; Mice; Oncogene Protein v-akt; Phosphatidylinositol 3-Kinases; Signal Transduction; Sirolimus; Time Factors; TOR Serine-Threonine Kinases | 2016 |
Reversible dysphasia and statins.
Topics: Anticholesteremic Agents; Antihypertensive Agents; Anxiety; Aphasia; Atorvastatin; Cytochrome P-450 Enzyme System; Depression; Drug Interactions; Female; Fluorobenzenes; Heptanoic Acids; Humans; Hypercholesterolemia; Indapamide; Middle Aged; Pyrimidines; Pyrroles; Rosuvastatin Calcium; Sulfonamides | 2012 |
Acute atorvastatin treatment exerts antidepressant-like effect in mice via the L-arginine-nitric oxide-cyclic guanosine monophosphate pathway and increases BDNF levels.
Topics: Animals; Antidepressive Agents; Arginine; Atorvastatin; Brain-Derived Neurotrophic Factor; Cyclic GMP; Depression; Heptanoic Acids; Male; Mice; Nitric Oxide; Pyrroles; Signal Transduction | 2013 |
Lipid-lowering drugs and the risk of depression and suicidal behavior.
Topics: Adult; Aged; Atorvastatin; Case-Control Studies; Depression; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Male; Middle Aged; Multivariate Analysis; Pyrroles; Regression Analysis; Risk Factors; Suicide | 2003 |